| |
MESSAGE _ENGLISH VERSION_
|
|
| |
Title: Preliminary estimates of revenues from the sale of products and services for Q1 2026 Legal basis: Article 17_1_ MAR - inside information. Content of the Report: The Management Board of XTPL S.A. ["Issuer", "Company", "XTPL"] hereby reports preliminary estimates of the Company's consolidated revenues from the sale of products and services for the first quarter of 2026. Estimated consolidated revenues from the sale of the Company's products and services in the first quarter of 2026 were PLN 1,229 thousand. In the same period of the previous year, revenues were PLN 2,024 thousand. This figure does not include proceeds on account of grants related to the Issuer's implementation of research and development projects. The main factor affecting sales in the first quarter of 2026 was the delivery of one Delta Printing System _DPS_ device to a customer in Taiwan and two Ultra-Precise Dispensing _UPD_ modules, including one to a direct partner in China, as part of the first-ever industrial deployment of XTPL technology, where the end client is a Chinese Flat Panel Display _FPD_ manufacturer with annual revenues exceeding USD 20 billion. The delivery of an UPD module to the partner in the first quarter of 2026 completed the first batch of deliveries agreed in January 2025. Currently, the Company is engaged in advanced negotiations aimed at securing a further batch of orders, with the expected delivery timeline within the 2026 horizon, which may have a positive impact on the results of subsequent periods. In the first quarter of 2026, the Company did not secure any new funding from grants. At the same time, it should be noted that, as a result of the recognition of deferred grant income, the Company may recognise revenue from this source. The Company is currently implementing two international grant-funded projects [Current Report 7/2022 of March 31, 2022 and Current Report 1/2024 of January 12, 2024]. In addition, in April 2026, the Company signed a funding agreement with the National Centre for Research and Development _NCBR_ for a new project with total funding of PLN 10.1 million [Current Report 20/2026 of April 17, 2026]. As project implementation is scheduled to commence on May 1, 2026, it should be assumed that the Company will report the acquisition of new grant funding by the end of the year. In the corresponding period of the previous year, the Company did not obtain any new grant funding. The estimated cash position at the end of the quarter amounted to PLN 2.4 million and did not include proceeds from the share issue completed during the period, under which the Issuer raised PLN 19.5 million gross from investors, which were received into the Company's bank account in April 2026. Together with the signed funding agreement, providing for total funding of PLN 10.1 million, the Company's financial position is stable and enables the execution of its 2026-2028 Strategy. A key element of the Strategy will comprise R_D and sales activities aimed at broader commercialisation of the new ODRA systems business line. The Company received its first order for the supply of an ODRA system on March 9, 2026 from an industrial client based in Silicon Valley, USA. The contract value is in the range of USD 0.4-0.5 million, and revenue from its execution will have a positive impact on financial results in Q4 2026. The Company is currently engaged in multiple ongoing sales processes aimed at securing further ODRA system orders with delivery expected in Q4 2026 or in 2027, which may have a positive impact on the results of subsequent periods. The above preliminary consolidated revenues from the sale of products and services achieved in the first quarter of 2026 have been deemed by the Issuer to constitute confidential information due to a significant change in their level compared with the corresponding period of the previous year. The Company's Management Board emphasizes that the above figures are estimated and preliminary data, which means that they may ultimately differ from those to be disclosed in financial statements.
|
|
|